home / stock / axim / axim news

AXIM News and Press, Axim Biotechnologies Inc From 09/30/20

Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AXIM - AXIM files patent for virus binding recombinant protein for SARS-CoV-2

AXIM Biotechnologies ([[AXIM]]) has filed a provisional patent for a recombinant virus binding protein ((VBP)) for SARS-CoV-2, and is now manufacturing the VBP.According number of studies, SARS-CoV-2’s spike protein enters human host cells by locking its receptor binding...
AXIM - AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 (COVID-19) and Begins Manufacturing

SAN DIEGO, Sept. 30, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announce...

AXIM - AXIM® Biotechnologies Files Patent for World's First Face Mask Designed to Capture SARS-CoV-2 COVID-19

SAN DIEGO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announce...

AXIM - AXIM Bio nabs additional US patent for anti-neoplastic compounds

The USPTO has issued a new Notice of Allowance to AXIM Biotechnologies ([[AXIM]] +0.4%) for a patent on anti-neoplastic compounds and methods targeting Quiescin Sulfhydryl Oxidase 1, an enzyme important for tumor cell growth, invasion and metastasis.Earlier this year, AXIM...
AXIM - AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Proprietary Compounds and Methods Targeting Tumor Metastasis Through QSOX1

SAN DIEGO, Sept. 22, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announce...

AXIM - AXIM Bio seeks emergency use of COVID-19 rapid diagnostic test

AXIM Biotechnologies  ( OTCQB:AXIM ) has filed an Emergency Use Authorization (EUA) application with the FDA for measuring COVID-19 neutralizing antibodies in plasma and serum through its rapid diagnostic test. More news on: AXIM Biotechnologies, Inc., Healthcare stocks news, R...

AXIM - AXIM® Biotechnologies Files Emergency Use Authorization With the FDA for First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies

SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced to...
AXIM - 4 Penny Stocks To Watch As Markets Reach Record Highs

Are These 4 On Your List Of Penny Stocks To Watch? Penny stocks are always on the move. But when the entire market experiences a lift, the momentum can be more compounded. Monday was another bullish day for the stock market. It continued buildings on its record-setting week last week. While...

AXIM - Axim Bio inks manufacturing deal for COVID-19 antibody test

AXIM Biotechnologies  ( OTCQB:AXIM ) has signed an exclusive limited licensing, manufacturing and distribution agreement with Florida-based Empowered Diagnostics LLC for high volume production of AXIM's rapid diagnostic test measuring levels of functional neutralizing antibodies to p...

AXIM - AXIM® Biotechnologies Signs Exclusive Licensing, Manufacturing and Distribution Agreement for High Volume Production of the COVID-19 Rapid Neutralizing Antibody Test

SAN DIEGO, Aug. 24, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc.  (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announ...
Previous 10 Next 10